Tongce Medical announced on February 23 that on February 13, 2026, Chairman Wang Yi increased his holdings by 10,500 shares, with an additional investment of 499,600 yuan; Director Huang Yuhua increased his holdings by 10,000 shares, with an additional investment of 476,050 yuan; Secretary Zhang Hua increased his holdings by 10,000 shares, with an additional investment of 473,310 yuan; other management personnel Zhao Min increased her holdings by 7,700 shares, with an additional investment of 367,100 yuan. The company’s directors and senior management plan to increase their holdings by a total of no less than 6 million yuan and no more than 12 million yuan (including the amount of shares increased on February 13, 2026) within six months from the date of this additional purchase through centralized bidding transactions. No price range has been set for this purchase. The company will implement the buyback plan based on stock price fluctuations and overall market trends at an appropriate time.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Tongce Medical: Chairman and others plan to increase their holdings of the company's shares by between 6 million and 12 million yuan
Tongce Medical announced on February 23 that on February 13, 2026, Chairman Wang Yi increased his holdings by 10,500 shares, with an additional investment of 499,600 yuan; Director Huang Yuhua increased his holdings by 10,000 shares, with an additional investment of 476,050 yuan; Secretary Zhang Hua increased his holdings by 10,000 shares, with an additional investment of 473,310 yuan; other management personnel Zhao Min increased her holdings by 7,700 shares, with an additional investment of 367,100 yuan. The company’s directors and senior management plan to increase their holdings by a total of no less than 6 million yuan and no more than 12 million yuan (including the amount of shares increased on February 13, 2026) within six months from the date of this additional purchase through centralized bidding transactions. No price range has been set for this purchase. The company will implement the buyback plan based on stock price fluctuations and overall market trends at an appropriate time.